The Surprising Power of Starting Young
Doctors have long known that earlier treatment is generally better. But a new 25-year study adds powerful, real-world clarity.
The old thinking was simply to start GH when a girl falls behind on growth charts. The new evidence sharpens that focus dramatically.
It shows that the clock starts ticking much earlier than we might think.
Think of a child’s growth like building a tower. The foundation and early floors are laid down during the first years of life. Growth hormone is the construction crew.
In Turner syndrome, this crew is understaffed from the beginning. The tower’s blueprint (the genetic code) has a note that says, “Stop building early.”
Starting GH therapy is like bringing in a bigger, more effective crew. If you bring them in while the foundation is still being poured, they can build a taller, stronger tower from the ground up.
If you wait until the top floors are being added, the crew can only do so much. The opportunity to influence the foundation is gone.
A Quarter-Century of Evidence
Researchers looked back at 25 years of care for 31 patients with Turner syndrome at one center. Their ages ranged from toddlers to adults.
They tracked everything: genetics, growth hormone use, final adult height, and long-term health issues.
A key part of the study was comparing girls who started GH at different ages. They grouped them as starting before age 6, between 6 and 12, and at age 12 or older.
The Height Difference is Measurable
The results were striking. The girls who started growth hormone at the youngest age—before turning 6—grew to be the tallest adults.
Their average final heights were in the range of 159 to 163 centimeters (about 5’3” to 5’4”).
Those who started therapy latest, at age 12 or older, had the shortest average adult heights. Their range was approximately 140 to 156 cm (about 4’7” to 5’1”).
The study found that for every year earlier that GH was started, there was a trend toward a better height outcome. This wasn’t just about genetics. Starting age itself was a powerful factor.
But There’s a Catch
This clear win for early treatment comes with a major warning.
The study followed these patients from childhood into adulthood. And it found that medical care often falls off a cliff after adolescence.
Turner syndrome is a lifelong condition. It requires ongoing check-ups for heart health, hearing, thyroid function, bone strength, and more.
Yet, among the 13 adult patients in this study who were supposed to transition to adult care, the results were alarming. Only one was seeing an endocrinologist regularly. Not a single one was getting the recommended heart imaging to monitor their aorta, a critical health risk in Turner syndrome.
Why the Gap is So Dangerous
An expert not involved in the study would likely point out this is a known, systemic problem. Pediatric care is often well-coordinated. Adult care is typically split among different specialists.
Patients get lost in the gap. This isn’t just about missing appointments. It’s about missing early signs of serious issues like heart valve problems, high blood pressure, or osteoporosis.
The study shows we’re getting better at the starting line but failing at the handoff.
What This Means for Your Family
If you have a daughter with Turner syndrome, this research reinforces a critical action point. Discuss the timing of growth hormone therapy with her pediatric endocrinologist as early as possible. The goal is to start treatment well before elementary school begins.
This study is a powerful reminder, not a new discovery.
It uses real-world data to confirm that the “early” in “early treatment” means very early.
The second, crucial takeaway is about lifelong care. Start the conversation about transitioning to adult medical care during the early teen years. Ask for a structured transition plan. This plan should include a clear list of which adult doctors to see and what tests are needed each year.
A Few Important Caveats
This study looked back at a relatively small group of patients at one medical center. Their experiences might not reflect everyone’s. The ideal starting age can also depend on the individual child’s specific growth pattern and other health factors.
The path forward has two clear lanes. First, the medical community must build stronger, structured bridges from pediatric to adult care. This means creating formal transition programs with checklists, shared records, and dedicated coordinators.
Second, for families, this study is a tool. It provides strong evidence to advocate for early treatment discussions. It also highlights the need to plan for adulthood from the very beginning. The goal is no longer just a better height. It’s a healthier, fully supported lifetime.
